Regorafenib Hydrochloride

≥99%

Reagent Code: #102270
fingerprint
CAS Number 835621-07-3

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 519.28 g/mol
Formula C₂₁H₁₆Cl₂F₄N₄O₃
inventory_2 Storage & Handling
Storage 2-8℃

description Product Description

Regorafenib Hydrochloride is primarily used in the treatment of certain types of cancer. It is specifically indicated for patients with metastatic colorectal cancer who have previously been treated with other therapies. Additionally, it is used for advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed or have stopped responding to other treatments. The drug is also approved for hepatocellular carcinoma (HCC), a type of liver cancer, in patients who have previously been treated with sorafenib.

The compound works by inhibiting multiple kinase enzymes involved in tumor growth, angiogenesis, and the tumor microenvironment. This helps to slow down or stop the progression of cancer by blocking the signals that promote cancer cell proliferation and blood vessel formation.

Patients are typically administered this medication orally, and it is often used as part of a broader treatment plan that may include other therapies. Regular monitoring is essential to manage potential side effects, which can include fatigue, hand-foot skin reaction, hypertension, and gastrointestinal issues.

format_list_bulleted Product Specification

Test Parameter Specification
Appearance Off White To White Solid
Purity (%) 98.5-100%
Infrared Spectrum Conforms To Structure
NMR Conforms To Structure

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 5mg
10-20 days ฿1,980.00
inventory 10mg
10-20 days ฿3,200.00
inventory 250mg
10-20 days ฿16,600.00
inventory 50mg
10-20 days ฿7,600.00
inventory bulk
10-20 days ฿0.00
inventory 1g
10-20 days ฿32,200.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB